Ieq Capital LLC Invests $482,000 in Alignment Healthcare, Inc. $ALHC

Key Points

• Ieq Capital LLC has acquired a new stake in Alignment Healthcare, Inc., purchasing 25,860 shares valued at approximately $482,000 during the first quarter.
• Insiders, including CEO John E. Kao, recently sold significant amounts of stock, leading to a decrease in their positions, with total insider sales in the last quarter amounting to over $9 million.
• Analysts have differing ratings on Alignment Healthcare, with a consensus rating of "Moderate Buy" and a price target of $18.83, while the stock has shown strong quarterly revenue growth of 49% year-over-year.

Ieq Capital LLC purchased a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 25,860 shares of the company's stock, valued at approximately $482,000.

Other hedge funds have also modified their holdings of the company. Teacher Retirement System of Texas raised its holdings in shares of Alignment Healthcare by 109.1% in the 1st quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company's stock worth $883,000 after buying an additional 24,755 shares in the last quarter. Northern Trust Corp raised its holdings in shares of Alignment Healthcare by 8.6% in the 4th quarter. Northern Trust Corp now owns 908,964 shares of the company's stock worth $10,226,000 after buying an additional 72,063 shares in the last quarter. New York State Common Retirement Fund raised its holdings in shares of Alignment Healthcare by 100.9% in the 1st quarter. New York State Common Retirement Fund now owns 165,642 shares of the company's stock worth $3,084,000 after buying an additional 83,187 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of Alignment Healthcare by 905.7% in the 1st quarter. Victory Capital Management Inc. now owns 114,397 shares of the company's stock worth $2,130,000 after buying an additional 103,022 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Alignment Healthcare by 3,216.9% in the 1st quarter. GAMMA Investing LLC now owns 23,815 shares of the company's stock worth $443,000 after buying an additional 23,097 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ALHC. Wall Street Zen cut Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Zacks Research raised Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. Stephens raised Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a report on Monday, August 25th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Alignment Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Price Performance

ALHC stock traded down $0.44 during midday trading on Friday, reaching $15.86. 2,222,047 shares of the company's stock traded hands, compared to its average volume of 2,700,272. The company has a market cap of $3.14 billion, a price-to-earnings ratio of -56.64 and a beta of 1.17. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a 50-day simple moving average of $14.18 and a two-hundred day simple moving average of $15.43. Alignment Healthcare, Inc. has a 1-year low of $8.65 and a 1-year high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business's quarterly revenue was up 49.0% compared to the same quarter last year. During the same period last year, the company earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, insider Robert L. Scavo sold 60,000 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $14.60, for a total value of $876,000.00. Following the transaction, the insider directly owned 642,953 shares in the company, valued at approximately $9,387,113.80. This trade represents a 8.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Monday, July 14th. The shares were sold at an average price of $13.44, for a total value of $403,200.00. Following the completion of the transaction, the president owned 2,042,899 shares in the company, valued at $27,456,562.56. The trade was a 1.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 636,185 shares of company stock worth $9,235,468. Corporate insiders own 7.00% of the company's stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.